<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211123053162N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-08-31</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>Therapeutic effect of Electro-Acupressure stimulation in knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of therapeutic effect of Electro-Acupressure stimulation in acupuncture points in reducing pain and stiffness and increasing knee joint function in patient with knee osteoarthritis: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>126</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60204</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to randomize the samples and assign them to three groups, since the sample size in each group is 42 people, the string of random numbers from 1 to 126, which are classified into three groups, was obtained through the Randomizer.org site and by The methodologist will receive and provide the researcher, Blinding description: The study is of the triple-blind trial, in such a way that the person completing the questionnaire and entering the data into the SPSS software is not aware of the intervention received by the patients. Also, the groups receiving the intervention and the control group are unaware of their placement in the group. For this purpose, in the control group, the electrode of the device touches the skin of the patient's knee in the areas outside the studied points, without any pressure and also without electric current. In this study, the methodologist is also unaware of the group of each patient in the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: intervention group (1): Simultaneous electrical and pressure stimulation. Patients receive both electrical pulse and pressure simultaneously at eight acupuncture points around the knee during 10 sessions of treatment with a TENS-Pen. Stimulation is performed in each point for one minute. Treatment is performed daily, five days a week for two week. Intervention 2: Intervention group (2): acupressure stimulation. In 10 sessions of therapy, they only receive pressure at eight points of acupuncture around the knee with a TENS-Pen. Stimulation is performed in each point for one minute. Treatment is performed daily, five days a week for two week. Intervention 3: Control group: placebo. In 10 sessions, the tip of the TENS-Pen electrode touch the fake points around the knee. Electrode contact is made in each point for one minute. This operation is performed daily, five days a week for two week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic data and results related to the main outcome

When:
If the report is published in open access journal, the access period starts 6 months after the article is published.

To whom:
For all researchers

Conditions:
If necessary, contact correspond author and if there is a reasonable justification for use in scientific purposes

Where to obtain:
Dr. Reza Maskani, Shahroud, 7thTir Square, Shahroud University of Medical Sciences; School of Nursing and Midwifery 02332395054 maskani.r@shmu.ac.ir

How to obtain:
By phone call or by email and registration of the request and stating the reason and purpose of the logical and approved up to two weeks

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Javad Hashemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hafte Tir Square</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773943</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>mohammadjavad.hashemi027@gmail.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Maskani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hafte Tir Square</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773943</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>maskani.r@shmu.ac.ir</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 45 years old
Patients who have been suffering from osteoarthritis of the knee for at least three months (according to the diagnosis of a rheumatologist).</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who have had a history of acupuncture points stimulation for any purpose in the past month.
Patients who have wound, scratch or abnormality in acupuncture points.
Patients who have used anticoagulants in the past month and also patients who have had a history of coagulation diseases in the past month.
Patients with a history of knee joint surgery (knee replacement).
Patients who have advanced neuropathy (pain, burning, tingling in the toes or feet and extreme sensitivity to surface touch).
Patients who are drug abuser.
Patients who have had any injection into the knee joint in the past month.
Patients who had a knee arthroscopy (a type of knee surgery that diagnoses and treats a knee joint problem) for 30 days prior to the intervention.
Patients who have unbearable severe pain in the knee that prevents them from participating in the study.
Patients with pacemakers.
Patients with transplanted tissue.
Pregnant patients.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>intervention group (1): Simultaneous electrical and pressure stimulation. Patients receive both electrical pulse and pressure simultaneously at eight acupuncture points around the knee during 10 sessions of treatment with a TENS-Pen. Stimulation is performed in each point for one minute. Treatment is performed daily, five days a week for two week.</i_keyword>
      <i_keyword>Intervention group (2): acupressure stimulation. In 10 sessions of therapy, they only receive pressure at eight points of acupuncture around the knee with a TENS-Pen. Stimulation is performed in each point for one minute. Treatment is performed daily, five days a week for two week.</i_keyword>
      <i_keyword>Control group: placebo. In 10 sessions, the tip of the TENS-Pen electrode touch the fake points around the knee. Electrode contact is made in each point for one minute. This operation is performed daily, five days a week for two week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee Pain. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: WOMAC and KOOS questionnaire, VAS ruler.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Knee joint stiffness. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: WOMAC and KOOS questionnaire.</sec_outcome>
      <sec_outcome>Clinical manifestation of the knee joint. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: WOMAC and KOOS questionnaire.</sec_outcome>
      <sec_outcome>Ability to perform daily tasks. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: WOMAC and KOOS questionnaire.</sec_outcome>
      <sec_outcome>Physical activity. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: KOOS questionnaire.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: Before the first session, two days after the last session and three weeks after the last session. Method of measurement: KOOS questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-06-13</approval_date>
        <contact_name>Research Ethics Committees of Shahroud University of Medical Sciences</contact_name>
        <contact_address>Hafte Tir Square shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
